Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-05 · accession 0000028823-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-08 | 2022-02-05 | DBD | Leiken Jonathan | EVP, CLO, Sec | F - Tax | $8.25 | -2,646 | 136.8K | -2% | -$21.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-02-05 | F | D | 2,646 | $8.25 | 136,844 | D | — | — | (F1) Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award (F2) Number includes restricted stock units. |